DGX logo

Quest Diagnostics IncorporatedNYSE:DGX Stock Report

Market Cap US$19.1b
Share Price
US$172.44
My Fair Value
AN
AnalystConsensusTarget
US$188
8.4% undervalued intrinsic discount
1Y18.3%
7D2.7%
Portfolio Value
View

Quest Diagnostics Incorporated

NYSE:DGX Stock Report

Market Cap: US$19.1b

Quest Diagnostics (DGX) Stock Overview

Provides diagnostic testing and services in the United States and internationally. More details

DGX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance4/6
Financial Health3/6
Dividends5/6

DGX Community Fair Values

Create Narrative

See what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.

Quest Diagnostics Incorporated Competitors

Price History & Performance

Summary of share price highs, lows and changes for Quest Diagnostics
Historical stock prices
Current Share PriceUS$172.44
52 Week HighUS$182.38
52 Week LowUS$144.87
Beta0.46
1 Month Change-2.53%
3 Month Change-2.08%
1 Year Change18.28%
3 Year Change23.15%
5 Year Change42.23%
Change since IPO4,826.86%

Recent News & Updates

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 15

Recent updates

Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today

Jul 15

Return Trends At Quest Diagnostics (NYSE:DGX) Aren't Appealing

Jun 21
Return Trends At Quest Diagnostics (NYSE:DGX) Aren't Appealing

Is Quest Diagnostics Incorporated (NYSE:DGX) Trading At A 48% Discount?

May 11
Is Quest Diagnostics Incorporated (NYSE:DGX) Trading At A 48% Discount?

Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80

Apr 03
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80

Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80

Mar 20
Quest Diagnostics (NYSE:DGX) Will Pay A Larger Dividend Than Last Year At $0.80

Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Mar 17
Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Is Increasing Its Dividend To $0.80

Feb 27
Quest Diagnostics (NYSE:DGX) Is Increasing Its Dividend To $0.80

Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger

Feb 19
Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger

Quest Diagnostics Incorporated (NYSE:DGX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Feb 02
Quest Diagnostics Incorporated (NYSE:DGX) Yearly Results: Here's What Analysts Are Forecasting For This Year

Quest Diagnostics: Good Growth Prospects, But Little To No Upside Left At Current Valuation

Jan 28

Quest Diagnostics Incorporated (NYSE:DGX) Could Be Riskier Than It Looks

Jan 26
Quest Diagnostics Incorporated (NYSE:DGX) Could Be Riskier Than It Looks

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Dec 18
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Nov 30
Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Nov 12
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
author-image

Expanding Geographic Footprint And Advancing Diagnostics Fuel Revenue And Margin Growth

Strategic expansions and acquisitions, like LifeLabs in Canada and select U.S. lab assets, aim to grow market share and access, potentially boosting revenues.

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics: Let's Keep Waiting

May 08

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Shareholder Returns

DGXUS HealthcareUS Market
7D2.7%-5.1%-1.2%
1Y18.3%-35.2%22.8%

Return vs Industry: DGX exceeded the US Healthcare industry which returned -36.1% over the past year.

Return vs Market: DGX underperformed the US Market which returned 20.5% over the past year.

Price Volatility

Is DGX's price volatile compared to industry and market?
DGX volatility
DGX Average Weekly Movement3.4%
Healthcare Industry Average Movement6.9%
Market Average Movement6.4%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market3.1%

Stable Share Price: DGX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: DGX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196750,500Jim Daviswww.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

Quest Diagnostics Incorporated Fundamentals Summary

How do Quest Diagnostics's earnings and revenue compare to its market cap?
DGX fundamental statistics
Market capUS$19.11b
Earnings (TTM)US$945.00m
Revenue (TTM)US$10.52b
20.4x
P/E Ratio
1.8x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DGX income statement (TTM)
RevenueUS$10.52b
Cost of RevenueUS$7.02b
Gross ProfitUS$3.50b
Other ExpensesUS$2.56b
EarningsUS$945.00m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)8.45
Gross Margin33.26%
Net Profit Margin8.98%
Debt/Equity Ratio77.2%

How did DGX perform over the long term?

See historical performance and comparison

Dividends

1.9%
Current Dividend Yield
37%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/04 05:13
End of Day Share Price 2025/08/04 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quest Diagnostics Incorporated is covered by 47 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Brian Kemp DolliverAvondale Partners
Eric ColdwellBaird